Amyloid‐beta plasma and cerebrospinal fluid biomarkers in aged dogs with cognitive dysfunction syndrome

BACKGROUND: Cognitive dysfunction syndrome (CDS) is a common progressive neurodegenerative disease that is poorly defined. Specific multitargeted protocols do not exist for setting the diagnosis and the prognosis of the syndrome. HYPOTHESIS/OBJECTIVES: To quantify Aβ42 and Aβ40 peptides in blood and...

Descripción completa

Detalles Bibliográficos
Autores principales: Stylianaki, Ioanna, Polizopoulou, Zoe S., Theodoridis, Alexandros, Koutouzidou, Georgia, Baka, Rania, Papaioannou, Nikolaos G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379053/
https://www.ncbi.nlm.nih.gov/pubmed/32557873
http://dx.doi.org/10.1111/jvim.15812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379053/
https://www.ncbi.nlm.nih.gov/pubmed/32557873
http://dx.doi.org/10.1111/jvim.15812

Ejemplares similares